1-3 of 3
François Gavini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effectiveness and Safety of Ixazomib-Based Therapy in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated Outside the Clinical Trial Setting Via an Early Access Program (EAP) in Europe: Second Interim Analysis of the 'Use Via Early Access to Ixazomib' (UVEA-IXA) Study

Heinz Ludwig, MD, Evangelos Terpos, MD PhD, María-Victoria Mateos, MD PhD, Mario Boccadoro, Bhuvan Kishore, Karthik Ramasamy, Sylvie Fernandez, Fabio Ferri, Nawal Bent-Ennakhil, Athanasios Zomas, François Gavini, Roman Hajek, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-136519
Published: 2020
Journal Articles

Real-World Treatment Patterns from the HUMANS Study in Multiple Myeloma in Denmark

Niels Abildgaard, MD, Anders Waage, MD PhD, Markus Hansson, MD PhD, Pekka Anttila, MD, Mate Szilcz, Yuanjun Ma, Katrine Hass Rubin, Lill-Brith von Arx, Sigurd Ørstavik, Nawal Bent-Ennakhil, Jonatan Freilich, François Gavini, Anders Green
Journal: Blood
Blood (2019) 134 (Supplement_1): 5030.
https://doi.org/10.1182/blood-2019-121953
Published: 2019
Journal Articles

Utilizing Multiple Linked Populations Registers to Estimate Incidence and Prevalence of Multiple Myeloma in Sweden and Denmark from the Real-World HUMANS Study

Markus Hansson, MD PhD, Niels Abildgaard, MD, Anders Waage, MD PhD, Pekka Anttila, MD, Anders Green, Katrine Hass Rubin, Lill-Brith von Arx, Mate Szilcz, Yuanjun Ma, Sigurd Ørstavik, Nawal Bent-Ennakhil, Jonatan Freilich, François Gavini
Journal: Blood
Blood (2019) 134 (Supplement_1): 5037.
https://doi.org/10.1182/blood-2019-121983
Published: 2019